Logo image
Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection
Journal article   Open access   Peer reviewed

Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection

T M Daly and C A Long
Infection and immunity, v 64(7), pp 2602-2608
Jul 1996
PMID: 8698485
url
https://doi.org/10.1128/iai.64.7.2602-2608.1996View
Published, Version of Record (VoR) Open

Abstract

Adjuvants, Immunologic - administration & dosage Animals Antibodies, Protozoan - blood Antigens, Protozoan - administration & dosage Immunization Immunoglobulin Isotypes - blood Malaria - immunology Malaria - prevention & control Malaria Vaccines - administration & dosage Male Merozoite Surface Protein 1 Mice Mice, Inbred BALB C Plasmodium yoelii - immunology Protein Precursors - administration & dosage Protein Precursors - immunology Protozoan Proteins - administration & dosage Protozoan Proteins - immunology Recombinant Fusion Proteins - administration & dosage Recombinant Fusion Proteins - immunology Species Specificity Vaccines, Synthetic - administration & dosage
Previously, we described a protective immune response induced by the carboxyl-terminal region of the merozoite surface protein-1 (MSP-1) from the rodent malarial parasite Plasmodium yoelii yoelii 17XL, expressed as a fusion protein and designated glutathione S-transferase (GST)-PYC2. We also demonstrated that the humoral response induced by GST-PYC2 was the primary mechanism by which immunized animals controlled their blood-stage infections. We have now examined the influence of several adjuvants on the immune response to the GST-PYC2 fusion protein. While alum, Freund's adjuvant, Ribi adjuvant system, and TiterMax were efficacious in eliciting a protective response with GST-PYC2 in BALB/c mice, saponin failed to induce protection, although significant levels of PYC2-specific antibodies were produced in all immunized animals. This protection depended on the mouse strain since immunization of Swiss Webster mice with GST-PYC2 in alum did not produce levels of PYC2-specific antibodies comparable to those in BALB/c mice nor did it induce any demonstrable level of protection against parasite challenge. Swiss Webster mice were protected, however, when immunized with GST-PYC2 in other adjuvants. Immunization with PYC2, isolated free of GST induced lower levels of antigen-specific antibody; only those animals given PYC2 in Freund's adjuvant demonstrated a significant degree of protection, suggesting the possibility (of additional cellular effector mechanisms. These findings demonstrate that adjuvant, host genotype, and the fine specificity of the response significantly influence the protection induced by the carboxyl terminus of MSP-1 in vivo and illustrate the need to consider these factors in evaluating MSP-1 as a vaccine component.

Metrics

7 Record Views
45 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Immunology
Infectious Diseases
Logo image